Galectin Therapeutics
GALT
#8074
Rank
A$0.25 B
Marketcap
$4.12
Share price
1.48%
Change (1 day)
38.09%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of June 2024 : A$38.39 M

According to Galectin Therapeutics's latest financial reports the company has A$38.39 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$27.32 M-49.9%
2021-12-31A$54.52 M54.81%
2020-12-31A$35.22 M-47.85%
2019-12-31A$67.54 M476.75%
2018-12-31A$11.71 M199.47%
2017-12-31A$3.91 M-81.65%
2016-12-31A$21.31 M-39.94%
2015-12-31A$35.48 M-0.11%
2014-12-31A$35.52 M202.06%
2013-12-31A$11.75 M30.21%
2012-12-31A$9.03 M44.76%
2011-12-31A$6.23 M7.22%
2010-12-31A$5.81 M1973.33%
2009-12-31A$0.28 M-39.05%
2008-12-31A$0.46 M-69.5%
2007-12-31A$1.5 M-79.39%
2006-12-31A$7.32 M19.98%
2005-12-31A$6.1 M-55.87%
2004-12-31A$13.83 M35.14%
2003-12-31A$10.23 M200.15%
2002-12-31A$3.41 M16.71%
2001-12-31A$2.92 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.46 B 3,714.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.37 B 867.89%๐Ÿ‡บ๐Ÿ‡ธ USA